home / stock / ipha / ipha news

IPHA News and Press, Innate Pharma S.A. From 09/17/25

Stock Information
Company Name: Innate Pharma S.A.
Stock Symbol: IPHA
Market: NASDAQ
Website: innate-pharma.com
Menu
IPHA IPHA Quote IPHA Short IPHA News IPHA Articles IPHA Message Board
Get IPHA Alerts

News, Short Squeeze, Breakout and More Instantly...
IPHA - Expected earnings - Innate Pharma S.A.

Innate Pharma S.A. (IPHA) is expected to report for Q2 2025
IPHA - Innate Pharma Reports First Half 2025 Business Update and Financial Results

IPH4502 Nectin-4 ADC Phase 1 enrollment progressing well: Preclinical update and Trial In Progress presented at AACR Annual Meeting 2025 and ASCO 2025 Annual Meeting. Lacutamab BTD and Phase 3 preparation: FDA Breakthrough Therapy Designation (BTD) in February 2025 based...

IPHA - Innate Pharma Announces Its Participation in the 25th Edition of the European Midcap Event

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“ Innate ” or the “ Company ”) today announced that Frédéric Lombard, Chief financial Officer of the Company, will participate in the 25 th edition of the European Midcap E...

IPHA - Innate Pharma Announces Conference Call and Webcast for First Half 2025 Financial Results and Business Update

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“ Innate ” or the “ Company ”), today announced that the Company will hold a conference call on Wednesday, September 17, 2025, at 2 p.m. CEST / 8 a.m. EDT, to give an update on business ...
IPHA - Number of Shares and Voting Rights of Innate Pharma as of September 1, 2025

Regulatory News: Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of the French stock-market authorities ( Autorité des Marchés Financiers , or “ AMF ”) General Regulation, Innate Pharma SA (Euronext Pari...

IPHA - Number of Shares and Voting Rights of Innate Pharma as of August 1, 2025

Regulatory news: Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of the French stock-market authorities ( Autorité des Marchés Financiers , or “ AMF ”) General Regulation, Innate Pharma SA (Euronext Pari...

IPHA - Innate Pharma Announces Its Participation in the BTIG Virtual Biotechnology Conference

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“ Innate ” or the “ Company ”) today announced that the company’s CEO Jonathan Dickinson and COO Yannis Morel will participate in the BTIG Virtual Biotechnology Conference being h...
IPHA - Buy Recommendation Issued On IPHA By BTIG

2025-07-28 08:15:05 ET BTIG analyst issues BUY recommendation for IPHA on July 28, 2025 10:10AM ET. IPHA was trading at $2.03 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 3 - Buy, 1 - Hold recommendati...

IPHA - Number of Shares and Voting Rights of Innate Pharma as of July 3, 2025

Regulatory News: Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of the French stock-market authorities ( Autorité des Marchés Financiers , or “ AMF ”) General Regulation, Innate Pharma SA (Euronext Pari...

IPHA - Innate Pharma Announces Its Participation in H.C. Wainwright and Wolfe Research Healthcare Conferences

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“ Innate ” or the “ Company ”) today announced that members of its executive team will participate in the upcoming investor conferences, detailed below. H.C. Wainwright 3 rd ...
Previous 10 Next 10